|
|
| HS016 (adalimumab biosimilar) / Zhejiang Hisun (0 Trials) |
|
| HS135 / 35Pharma (0 Trials) |
|
| HS215 / Stemgen (0 Trials) |
|
| HS216 / Stemgen (0 Trials) |
|
| HS217 / Stemgen (0 Trials) |
|
| HS219α&β / Stemgen (0 Trials) |
|
| HS269 / Zhejiang Hisun (0 Trials) |
|
| HS627 (pertuzumab biosimilar) / Zhejiang Hisun (0 Trials) |
|
| HS630 / Zhejiang Hisun, Beijing Mabworks Biotech (0 Trials) |
|
| HS632 (omalizumab biosimilar) / Zhejiang Hisun (0 Trials) |
|
| HSB-114 / Hillstream BioPharma (0 Trials) |
|
| HSB-1940 / Hillstream BioPharma (0 Trials) |
|
| HSB-510 / Hillstream BioPharma (0 Trials) |
|
| HSB-888 / Hillstream BioPharma (0 Trials) |
|
| HSC-2923 / Protheragen (0 Trials) |
|
| HSD-016 / Pfizer (0 Trials) |
|
| HSK21542 / Haisco (0 Trials) |
|
| HSK29116 / Haisco (0 Trials) |
|
| HSK31679 / Haisco (0 Trials) |
|
| HSK31858 / Chiesi (0 Trials) |
|
| HSK40118 / Haisco (0 Trials) |
|
| HSK7653 / Haisco (0 Trials) |
|
| HSP60-Treg / Sangamo Therap (0 Trials) |
|
| HSP90 Inhibitor / NexGenix (0 Trials) |
|
| HSP90/TRAP1 inhibitor / Collidion (0 Trials) |
|
| Hsps modulator / Collidion (0 Trials) |
|
| HSRx-888 / HSRx (0 Trials) |
|
| HST 001 / Histogen (0 Trials) |
|
| HST-1011 / HotSpot Therap (0 Trials) |
|
| HSV G207 / Treovir (0 Trials) |
|
| HSV vaccine (GEN-003) / Genocea, Shionogi (1 Trials) |
|
| HSV-2 vaccine (HSV529) / Sanofi, Merck (MSD) (0 Trials) |
|
| HSV-2 vaccine-Novavax / Novavax (0 Trials) |
|
| HSV2 vaccine (G103) / Merck (MSD), Sanofi (0 Trials) |
|
| HSY244 / Novartis (0 Trials) |
|
| HT-002 / Hoth Therap (0 Trials) |
|
| HT-003IBD / Hoth Therap (0 Trials) |
|
| HT-0712 / Dart NeuroScience (0 Trials) |
|
| HT-1067 / Dart NeuroScience (0 Trials) |
|
| HT-6184 / Halia Therap (0 Trials) |
|
| HT-ALZ / Hoth Therap (0 Trials) |
|
| HT-KIT / Hoth Therap, NC State University (0 Trials) |
|
| HTCC / Jagiellonian University (0 Trials) |
|
| HTD2802 / HighTide Therap (0 Trials) |
|
| HTI-1090 / Jiangsu Hengrui Pharma (1 Trials) |
|
| HTI-1511 / Halozyme (0 Trials) |
|
| HTI-501 / Halozyme (0 Trials) |
|
| HTL-001 / HOX Therap (0 Trials) |
|
| HTL0009936 / Sosei (0 Trials) |
|
| HTL0016878 / Neurocrine (1 Trials) |
|
| HTL0018318 / Sosei (1 Trials) |
|
| HTL0039732 / Sosei (0 Trials) |
|
| HTL’023 / Sosei (0 Trials) |
|
| HTL’097 / Sosei (0 Trials) |
|
| HTR-2001 / Protheragen (0 Trials) |
|
| hTREM1-IgG fusion protein (TREM-1) / Novo Nordisk (0 Trials) |
|
| HTX-001 / HAYA Therap (0 Trials) |
|
| Hu-Mik-Beta-1 / National Institute of Neurological Disorders and Stroke (0 Trials) |
|
| Hu2C3 Ab / Avid Bioservices (0 Trials) |
|
| HU6 / Rivus Pharma (0 Trials) |
|
| HuABC2 / JN Biosci (0 Trials) |
|
| huB7-H3 / Y-mAbs Therap (0 Trials) |
|
| HUC-MSCs / Zhongyuan Union Cell & Gene (0 Trials) |
|
| HUC3-413 / Huons (0 Trials) |
|
| huCART19 / Novartis (5 Trials) |
|
| huCD33-BsAb / Y-mAbs Therap (0 Trials) |
|
| HuCNS-SC / Microbot Medical (0 Trials) |
|
| HuFeron (Interferon-β) / CytoPharm (0 Trials) |
|
| HuGOH729S / JN Biosci (0 Trials) |
|
| huHER3-8 / AbbVie (0 Trials) |
|
| Hukyndra (adalimumab biosimilar) / Cipla, Alvotech, Stada, Teva, JAMP Pharma, YAS Holding (0 Trials) |
|
| HuL001 / HuniLife Biotech (0 Trials) |
|
| Hulio (adalimumab-fkjp) / Fujifilm Kyowa Kirin Biologics, Biocon (5 Trials) |
|
| huLym-1 DAP CAR-T cell therapy / Cell BT (0 Trials) |
|
| Humabody VH antibody fragment-based CAR-T cell therapy / Crescendo Biologics, Takeda (0 Trials) |
|
| Humalog ILPS (insulin lispro protamine suspension) / Eli Lilly (0 Trials) |
|
| Humalog Mix 50/50 (insulin lispro protamine 50% + insulin lispro 50%) / Eli Lilly (0 Trials) |
|
| Humalog Mix75/25 Kwikpen (lispro protamine/ lispro) / Eli Lilly (0 Trials) |
|
| Humalog pen (insulin lispro) / Eli Lilly (16 Trials) |
|
| Humalutin (177Lu-DOTA-NNV003) / Nordic Nanovector (0 Trials) |
|
| human adipose derived mesenchymal progenitor cell therapy / Cellular Biomedicine (1 Trials) |
|
| Human Albumin Biotest (human albumin) / ADMA Biologics (0 Trials) |
|
| Human Albumin Grifols (human albumin) / Grifols (0 Trials) |
|
| human allogeneic myeloid progenitor cells (CLT-008) / Cellerant Therap (0 Trials) |
|
| human alpha-1 antitrypsin / CEVEC (0 Trials) |
|
| human amniotic epithelial stem cells (hAESCs) / iCELL Biotechnology (0 Trials) |
|
| Human Amniotic Fluid / University of Utah (0 Trials) |
|
| human anti CD19 CAR-T cells / Case Comprehensive Cancer Center (0 Trials) |
|
| human beta defensin-2 (hBD-2) / Defensin Therap (0 Trials) |
|
| Human Cytomegalovirus Immunoglobulin / China Biologic Products (0 Trials) |
|
| human factor VIII (FVIII) / DNARx (0 Trials) |
|
| human fibrinogen / China Biologic Products (0 Trials) |
|
| human hepatitis B immunoglobulin / China Biologic Products (0 Trials) |
|
| human IL-22 / Synlogic (0 Trials) |
|
| human immune globulin IV 10% / Sichuan Yuanda Shuyang Pharma (0 Trials) |
|
| human immune globulin IV 10% (IVIG) / Liminal BioSci (1 Trials) |
|
| human immunoglobulin (pH4) for intravenous injection / Peking Union Medical College (0 Trials) |
|
| human immunoglobulin G IV (GC5101B) / GC Biopharma (0 Trials) |
|
| human immunoglobulin intramuscular / Shanghai RAAS (0 Trials) |
|
| human immunoglobulin intravenous 10% / Hualan Biological Engineering (0 Trials) |
|
| human immunoglobulin intravenous 10% / China Biologic Products (0 Trials) |
|
| human immunoglobulin intravenous 5% / China Biologic Products (0 Trials) |
|
| human immunoglobulin intravenous 5% / Hualan Biological Engineering (0 Trials) |
|
| human interferon alpha 2b / Generic mfg. (0 Trials) |
|
| human interferon alpha-2b (IFN-α XL) / Avadel (0 Trials) |
|
| human interleukin-2 inhalation / Immunservice (0 Trials) |
|
| human iPSC-derived GABAergic interneuron progenitors / GABAeron (0 Trials) |
|
| human menstrual blood derived stem cells / Zhejiang University (0 Trials) |
|
| human neural stem cells expressing IGF-1 (NSI-532.IGF) / Palisade Bio (0 Trials) |
|
| Human Papiloma Virus Vaccine / iBio (0 Trials) |
|
| human plasma-derived alpha-1 anti-trypsin deficiency biotherapeutic / Liminal BioSci (0 Trials) |
|
| human primary retinal pigment epithelial cells / Eyecure Therap (0 Trials) |
|
| human recombinant apoA-I/sphingomyelin/dipalmitoylphosphatidylglycerol (CER-001) / Abionyx Pharma (2 Trials) |
|
| human recombinant dHGF (CSB-001) / Claris Biotherap (0 Trials) |
|
| human retinal progenitor cell therapy / jCyte (1 Trials) |
|
| human retinal progenitor cells / ReNeuron (0 Trials) |
|
| human Rhodopsin / Kubota (0 Trials) |
|
| human stem cell-derived dopamine neurons cell therapy / Neurona Therap (0 Trials) |
|
| human tonsil-derived mesenchymal stem cell (CT303) / GC Biopharma (0 Trials) |
|
| Human tyrosinase DNA Vaccine / Ingro Finanz (0 Trials) |
|
| human umbilical cord derived mesenchymal stem cell therapy / First Affiliated Hospital of Nanchang University (0 Trials) |
|
| human umbilical cord derived mesenchymal stem cell therapy (UC-MSC) / Hunan GuangXiu-Gaoxin Life Sci (0 Trials) |
|
| human umbilical cord derived mesenchymal stem cells / Shandong University (0 Trials) |
|
| human umbilical cord derived mesenchymal stem cells / Hubei Shiyan Taihe Hospital, Beijing Darwin Cell Biotech (0 Trials) |
|
| Human umbilical cord mesenchymal stem cell injection / Shanghai Life Science & Technology (0 Trials) |
|
| human umbilical mesenchymal stem cell therapy (UC-MSCs) / Wuhan Hamilton Biotech, Wuhan Union Hospital (0 Trials) |
|
| humanised dinutuximab (Hu14.18K322A) / Essential Pharma (1 Trials) |
|
| humanized CD19 CAR-T cell therapy / Shanghai Yake Biotech (0 Trials) |
|
| humanized CD19 CAR-T cells / Shanghai Unicar (0 Trials) |
|
| humanized IgG (MORAb-066) / Eisai (0 Trials) |
|
| humantakinogene hadenovec (PCRX-201) / Pacira (0 Trials) |
|
| HuMax-CD4 (zanolimumab) / Emergent Biosolutions (0 Trials) |
|
| HuMax-CD74-ADC / Genmab, Pfizer (0 Trials) |
|
| humax-cMet / Genmab (0 Trials) |
|
| HuMax-EGFR (zalutumumab) / Genmab (0 Trials) |
|
| HuMax-Her2 / Genmab (0 Trials) |
|
| Humia (hyaluronic acid) / Huons (0 Trials) |
|
| Humin (human albumin) / Claris (0 Trials) |
|
| Humira (adalimumab) / AbbVie (189 Trials) |
|
| Humira SC (adalimumab/hyaluronidase) / AbbVie (3 Trials) |
|
| huMNC2-CAR22 / Minerva Biotech (0 Trials) |
|
| huMNC2-CAR44 CAR T cells / Minerva Biotech (1 Trials) |
|
| huMSC-derived mesenchymal trophic factors (MTF) / Medistem Panama (1 Trials) |
|
| Humulin 50/50, Huminsulin 50/50 (isophane insulin 50% + recombinant human insulin 50%) / Eli Lilly (0 Trials) |
|
| Humulin 70/30, Huminsulin 30/70 (isophane insulin 70% + recombinant human insulin 30%) / Eli Lilly (0 Trials) |
|
| Humulin N (isophane insulin) / Eli Lilly (2 Trials) |
|
| Humulin R (recombinant human insulin) / Alzheimer's Disease Cooperative Study, Eli Lilly (11 Trials) |
|
| Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma (1 Trials) |
|
| Huntexil (pridopidine) / Prilenia (3 Trials) |
|
| Huntington’s disease therapeutic / Suven Life Sci (0 Trials) |
|
| Huntington’s disease therapeutic / Anima Biotech, Takeda (0 Trials) |
|
| Huntington’s disease therapeutic / Avergen Pharma (0 Trials) |
|
| HuOHX10 / JN Biosci (0 Trials) |
|
| huperzine A (SPN-817) / Supernus Pharma (0 Trials) |
|
| huperzine A (XEL 001HP) / Xel Pharma (0 Trials) |
|
| huTNFalpha kinoid / Debiopharm (0 Trials) |
|
| Hutrukin / XBiotech (0 Trials) |
|
| Hutruo (bermekimab IV) / J&J (0 Trials) |
|
| HuYON007 / JN Biosci (0 Trials) |
|
| HV-107 / University of Puerto Rico (0 Trials) |
|
| hV01 / ConVerd (0 Trials) |
|
| hVEGF26–104/RFASE / Immunovo (0 Trials) |
|
| HW-CX01 / Huawe Medicine (0 Trials) |
|
| HWH340 / WuXi AppTec, Humanwell Healthcare (0 Trials) |
|
| HX-009 / Waterstone Hanxbio, HanX Biopharma (0 Trials) |
|
| HX-013 / Hangzhou Hansi Biomedicine (0 Trials) |
|
| HY-006B7 / Helperby Therap (0 Trials) |
|
| HY-0102 / HyaMab (0 Trials) |
|
| HY003 / Juventas Cell Therapy (0 Trials) |
|
| HY004 / Juventas Cell Therapy (0 Trials) |
|
| HY007 / Juventas Cell Therapy (0 Trials) |
|
| HY008 / Juventas Cell Therapy (0 Trials) |
|
| HY012 / Juventas Cell Therapy (0 Trials) |
|
| HY015 / Juventas Cell Therapy (0 Trials) |
|
| HY024 / Juventas Cell Therapy (0 Trials) |
|
| Hyalolex (IGC-AD1) / IGC Pharma (0 Trials) |
|
| Hyalostel One (sodium hyaluronate) / Stelis Biopharma (0 Trials) |
|
| hyaluronic acid (JTA-004) / BioSenic (0 Trials) |
|
| hyaluronic acid (YYD302) / Yooyoung Pharma (0 Trials) |
|
| hyaluronic acid/rexlemestrocel-L / Mesoblast (0 Trials) |
|
| hyaluronic acid/silver sulfadiazine / Generic mfg. (0 Trials) |
|
| HyBryte (synthetic hypericin) / Soligenix (0 Trials) |
|
| Hydexor (promethazine/hydrocodone/acetaminophen) / Daiichi Sankyo, Charleston Labs (0 Trials) |
|
| hydralazine hydrochloride / Generic mfg. (9 Trials) |
|
| hydrochlorothiazide / Generic mfg. (37 Trials) |
|
| hydrocodone (EG-P113) / Assertio (0 Trials) |
|
| hydrocodone (PTI-721) / Cassava (0 Trials) |
|
| hydrocodone / paracetamol (QSC-001) / Mallinckrodt (0 Trials) |
|
| hydrocodone and acetaminophen (MNK-155) / Mallinckrodt (0 Trials) |
|
| hydrocodone bitartrate / Generic mfg. (0 Trials) |
|
| hydrocodone bitartrate/acetaminophen immediate-release tablets (TV-46763) / Teva (0 Trials) |
|
| hydrocodone bitartrate/chlorpheniramine maleate/pseudoephedrine hydrochloride / Generic mfg. (0 Trials) |
|
| hydrocodone DETERx (COL-195) / Collegium Pharma (0 Trials) |
|
| hydrocodone IR (PF6129) / Ensysce Biosciences (0 Trials) |
|
| hydrocodone polistirex/chlorpheniramine polistirex XR / Generic mfg. (0 Trials) |
|
| hydrocodone/chlorpheniramine / Generic mfg. (0 Trials) |
|
| hydrocodone/paracetamol / Generic mfg. (8 Trials) |
|
| hydrocortisone / Generic mfg. (129 Trials) |
|
| hydrocortisone acetate rectal aerosol / Generic mfg. (0 Trials) |
|
| hydrocortisone acetate rectal cream / Generic mfg. (6 Trials) |
|
|